Synovial sarcoma of the popliteal fossa

Snezana B. Knezevic; Biljana  R. Srećković; Jelena A. Vulović; Marijana S. Jandrić-Kočić

doi:10.2298/AOO200915001K

Snezana B. Knezevic Primary Health Center, Jug Bogdanova 110, 36000 Kraljevo, Serbia https://orcid.org/0000-0001-9137-2122
Biljana R Srećković Primary Health Center, Jug Bogdanova 110, 36000 Kraljevo, Serbia
Jelena A. Vulović General Hospital, Department for Anesthesiology and Reanimation, Majora Marka 12, 35250 Paraćin, Serbia
Marijana S. Jandrić-Kočić Primary Health Care Center, Milana Jelića 2, 79227 Krupa na Uni, Republika Srpska, Bosnia and Hercegovina

DOI: https://doi.org/10.2298/AOO200915001K

Keywords: Synovial sarcoma, knee, neoplasms

Abstract

Soft tissue sarcomas are heterogeneous group of neoplasms making up to 1% of all malignant tumors in the adult population. The tumor generally appears on the extremities near large joints of middle-aged patients, especially in the popliteal fossa. Our patient presented in February 2014 due to a slowly enlarging, darker-colored swelling in the left popliteal fossa. Upon physical examination, a somewhat nodular, immobile, tender subcutaneous mass was observed. There was no locoregional lymphadenopathy. Patohistological findings showed a high-grade primary malignant mesenchymal tumor, biphasic synovial sarcoma type. The patient underwent surgery with wide surgical excision, followed by radiotherapy treatment. Magnetic resonance imagining follow up after one year revealed tumor recurrence. Neurovascular bundle involvement was detected, but without adjacent bone and muscular invasion and above-the-knee partial amputation of the left leg was performed. The intervention resulted in a remission of the neoplastic process and the patient was scheduled for regular check-ups. Broad surgical resection of the tumor with negative margins was the primary treatment in this case. Mutilating operations are necessary when anatomical structures around the tumor do not allow complete reintervention.

Author Biography

Snezana B. Knezevic, Primary Health Center, Jug Bogdanova 110, 36000 Kraljevo, Serbia

Live and work in city Kraljevo, Serbia. Graduated at the Faculty of Medicine in Kragujevac, Serbia, in 1994, the specialization in General Medicine in 2010 and full time employed a general practitioner in Health centre Kraljevo. In my team there are 1800 patients and I care about their health through preventive and curative. The coordinator in my city for violence against women, also member of Multisector team for domestic violence. Healthcare worker Educator on Domestic violence (Population fund United Nations UNFPA Serbia). Member of the Presidency and Scientific committee of the Serbian Medical Society, General Medicine Section. Writing scientific research papers, so far have 33 published. Investigated the doctor's attitude towards violence against women as well as the barrier in detecting more cases of violence against women. In 2019 became a member of the WONCA special interest group for Family Violence. I currently participate in the project IMOCAFV, supported by WONCA WORLD, WONCA EUROPE, EGPRN, EUROPREV and Vasco da Gama, translating questionnaire and forming a national team as national coordinator. Montegut scholar award winner for Wonca Europe region for 2019. Became a member of EGPRN last year and planning to take part in next EGPRN conference in Goeteborg. Reviewer for abstracts for 25^th WONCA Europe Conference in Berlin. The European Primary Care Cardiovascular Society (EPCCS) member also since 2019.

References

Aytekin MN, Öztürk R, Amer K, Yapar A. Epidemiology, incidence, and survival of synovial sarcoma subtypes: SEER database analysis. J Orthop Surg (Hong Kong). 2020 Jan-Apr;28(2):2309499020936009.

Pisani M, Al-Buheissi S, Whittlestone T. Retroperitoneal liposarcomas: a representative literature review occasioned by a rare case of laterelapse abdominal liposarcoma. Urologia. 2016;83(2):68-70.

Brunicardi FC. Schwartz’s Principles of Surgery. Tenth edition. Mc Graw Hill Education; 2015.

Casali PG, Abecassis N, Bauer S, Biagini R, Bielack S, Bonvalot S, et al. Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;00:1-11.

Taylor BS, Barretina J, Maki RG, Antonescu CR, Singer S, Ladanyi M. Advances in sarcoma genomics and new therapeutic targets. Nat Rev Cancer. 2011;11:541–57.

Keung EZ, Somaiah N. Overview of liposarcomas and their genomic landscape. J Transl Genet Genom 2019;3:8. http://dx.doi.org/10.20517/jtgg.2019.03

Kritsaneepaiboon S, Sangkhathat S, Mitarnun W. Primary synovial sarcoma of the abdominal wall: a case report and literature review. J Radiol Case Rep. 2015; 9(7):47-52.

Rüdiger H, Beltrami G, Campanacci D, Mela M, Franchi A, Capanna R. Soft tissue sarcomas of the popliteal fossa: Outcome and risk factors. EJSO 2007;33(4):512–517. doi:10.1016/j.ejso.2006.11.009

Braham E, Aloui S, Aouadi S, Drira I, Kilani T, El Mezni F. Synovial sarcoma of the chest wall: a case report and literature review. Ann Transl Med. 2013;1(1):9-12.

Hager S, Makowiec F, Henne K, Hopt UT, Wittel UA. Significant benefits in survival by the use of surgery combined with radiotherapy for retroperitoneal soft tissue sarcoma. Radiat Oncol. 2017;12(29):3-9.

Enzinger FM, Weiss SW. Soft tissue tumors, 3rd ed. St. Louis: Mosby-Year Book. 1995.

Fujimura T, Okuyama R, Terui T, Okuno K, Masu A, Masu T, et al. Myxofibrosarcoma (myxoid malignant fibrous histiocytoma) showing cutaneous presentation: report of two cases. J Cutan Pathol. 2005;32(7):512-15.

Pelmus M, Guillou L, Hostein I, Sierankowski G, Lussan C, Coindre JM. Monophasic fibrous and poorly differentiated synovial sarcoma: immunohistochemical reassessment of 60 t(X;18) (SYT-SSX)-positive cases. Am J Surg Pathol. 2002;26(11):1434-40.

Heim S, Mitelman F. Cancer cytogenetics: chromosomal and molecular genetic aberrations of tumor cells, 4th ed. Oxford: Wiley Blackwell; 2015.

Mitelman F, Johansson B, Mertens F. Mitelman database of chromosome aberrations and Gene fusions in cancer. 2017. http://cgap.nci. nih.gov/Chromosomes/Mitelman. (posećeno jun 2018.)

Mandahl N, Magnusson L, Nilsson J, Viklund B, Arbajian E, Vult von Steyern F, et al. Scattered genomic amplification in dedifferentiated liposarcoma. Mol Cytogenet. 2017;10:25-35.

Thway K, Fisher C. Synovial sarcoma: defining features and diagnostic evolution. Ann Diagn Pathol. 2014;18(6):369-380.

Toulmonde M, Bonvalot S, Méeus P, Stoeckle E, Riou O, Isambert N, et al. Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group. Ann Oncol. 2014;25(3):735-42.

Sampath S, Hitchcock YJ, Shrieve DC, Randall RL, Schultheiss TE, Wong JY. Radiotherapy and extent of surgical resection in retroperitoneal soft-tissue sarcoma: multi-institutional analysis of 261 patients. J Surg Oncol. 2010;101(5):345-50.

Pisters PW, O’Sullivan B, Maki RG. Evidence-based recommendations for local therapy for soft tissue sarcomas. J Clin Oncol. 2007;25(8):1003-08.

Beane JD, Yang JC, White D, Steinberg SM, Rosenberg SA, Rudloff U. Efficacy of adjuvant radiation therapy in the treatment of soft tissue sarcoma of the extremity: 20-year follow-up of a randomized prospective trial. Ann Surg Oncol. 2014;21:2484-2489.

Cahlon O, Brennan MF, Jia X, Qin LX, Singer S, Alektiar KM. A postoperative nomogram for local recurrence risk in extremity soft tissue sarcomas after limb-sparing surgery without adjuvant radiation. Ann Surg. 2012;255:343-347.

Judson I, Verweij J, Gelderblom H, Hartmann JT, Schöffski P, Blay J. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. Lancet Oncol. 2014;15:415-423.

Tap WD, Jones RL, Van Tine BA, Rodenhuis S, Keizer HJ, Van Hoesel Q. Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial. Lancet. 2016;388:488-497.

Miljković AR. Liposarkom - značaj kliničkog prepoznavanja od strane lekara opšte medicine. Opšta medicina. 2020;26(1-2):36-41.